OAM
OXFD

Oppenheimer Asset Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Oppenheimer Asset Management’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,556
Closed -$51K – 1514
2020
Q1 		$51K Buy
5,556
+864
+18% +$12.1K ﹤0.01% 1260
2019
Q4 		$78K Buy
+4,692
New +$76.1K ﹤0.01% 1256

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Oppenheimer Asset Management's OXFD Position: Q2 2020 in Review

Oppenheimer Asset Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2020, closing a stake of 5,556 shares — an estimated $51K sold.

Oppenheimer Asset Management first reported a position in OXFD in Q4 2019 and held it in 2 quarters. The position peaked at $78K in Q4 2019. 65 funds tracked by Wall St. Rank hold OXFD as of Q2 2020.

  • Oppenheimer Asset Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2020 after selling out during the quarter.
  • Oppenheimer Asset Management sold 5,556 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2020, an estimated $51K.
  • Oppenheimer Asset Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2019 and held it in 2 quarters.
  • Oppenheimer Asset Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $78K in Q4 2019.
  • 65 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2020.

Based on Oppenheimer Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.